Back to Journals » Cancer Management and Research » Volume 12

Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum]

Authors Chang J, Hong L, Liu Y, Pan Y, Yang H, Ye W, Xu K, Li Z, Zhang S

Received 28 April 2020

Accepted for publication 28 April 2020

Published 12 May 2020 Volume 2020:12 Pages 3331—3332

DOI https://doi.org/10.2147/CMAR.S260280


Chang J, Hong L, Liu Y. Cancer Manag Res. 2020;12:2641–2651.

The authors have advised that there is an error in Figure 2E on page 2646. 

The authors apologize for this error.
 
Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]